Literature DB >> 12200724

[What consequences will have the introduction of German Diagnosis Related Groups (G-DRGs) in surgical departments?].

H B Reith1.   

Abstract

With the planned introduction of Diagnosis related groups (DRG) in the German in-patient reimbursement system an economic brake will be put on the hospitals. The upcoming expected growth of the older German population and the ongoing process of better diagnostic and therapeutic procedures leads to a gap between costs and resources in the established health care system. With the introduction of the DRGs starts a process of one payment for one main diagnosis in hospital care. This requires a better resource control and leads to a tightrope walk between medical and economic aspects. The short time consequences result in great efforts of correct coding of diagnoses and procedures, as a survival strategy for surgical departments. More or less are new structures necessary, the development of "clinical pathways" and the increase or decrease of capacities will become the main tasks in the next years.

Entities:  

Mesh:

Year:  2002        PMID: 12200724     DOI: 10.1055/s-2002-33569

Source DB:  PubMed          Journal:  Zentralbl Chir        ISSN: 0044-409X            Impact factor:   0.942


  3 in total

1.  [Thoughts on the economic aspects of management of severely injured patients with reference to "diagnostic related groups" (DRG). An initiative of the Specialized Committee of the German Health Care System].

Authors:  H-C Pape; L Mahlke; O Schaefer; C Krettek
Journal:  Unfallchirurg       Date:  2003-10       Impact factor: 1.000

2.  [Is polytrauma affordable these days? G-DRG system vs per diem charge based on 1,030 patients with multiple injuries].

Authors:  B Qvick; V Buehren; A Woltmann
Journal:  Unfallchirurg       Date:  2012-10       Impact factor: 1.000

3.  [Case allocation of extensive operations on head and neck within the German DRG system 2004-2007: what is the net result of the continued developments in case allocation?].

Authors:  D Franz; K Franz; N Roeder; K Hörmann; R-J Fischer; Jürgen Alberty
Journal:  HNO       Date:  2007-07       Impact factor: 1.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.